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Introduction: The purpose of this article was to evaluate the quality of sample size calculation
reports in published clinical trials in Journal of Endodontics and International Endodontic Journal
in years 2000-1 and 2009-10. Materials and Methods: Articles fulfilling the inclusion criteria were
collected. The criteria were: publication year, research design, types of control group, reporting
sample size calculation, the number of participants in each group, study outcome, amount of type
I (α) and II (β) errors, method used for estimating prevalence or standard deviation, percentage of
meeting the expected sample size and considering clinically importance level in sample size
calculation. Data were extracted from all included articles. Descriptive analyses were conducted.
Inferential statistical analyses were done using independent T-test and Chi-square test with the
significance level set at 0.05. Results: There was a statistically significant increase in years between
2009 and 10 compared to 2000-1 in terms of reporting sample size calculation (P=0.002),
reporting clinically importance level (P=0.003) and in samples size of clinical trials (P=0.01). But
there was not any significant difference between two journals in terms of reporting sample size
calculation, type of control group, frequency of various study designs and frequency of positive
and negative clinical trials in different time periods (P>0.05). Conclusion: Sample size calculation
in endodontic clinical trials improved significantly in 2009-10 when compared to 2000-1; however
further improvements would be desirable.
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vidence-based medicine (EBM) can be interpreted as the
integration of the best and highest research evidence,
clinical expertise and patient values, was first introduced
by Dr. David Sackett in 1996 [1] and quickly gained dental
practitioners’ attention in a short time. In EBM, double blinded
randomized clinical trials are the gold standard for research
methodology and provide valuable evidence in answer to
clinical problems [2]. In clinical trials, the more accurate and
unbiased the design of a study, the more reliable and relevant
the results will be.
The CONSORT guideline consists of a detailed
checklist for reporting randomized controlled trials (RCTs),
which is suggested for preparing the reports of RCTs
According to this guideline, reporting the method of sample
size calculation is mandatory for all clinical trials to be
published [3].
Sample size calculation is essential before the start of
RCTs to provide adequate power to detect significant
differences among groups. If the sample size is not adequate,
the likelihood of type I and II errors will increase. On the
other hand, due to ethical and economic reasons, oversized
trials need to be avoided. It is therefore important to optimize
the sample size [4].
The importance of sample size calculation was
emphasized in some published articles. In one study, 71 RCTs
with negative results were reviewed to evaluate the sample
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Table 1. Frequency of published clinical trials in two endodontic journals in 2000-1 and 2009-10
Journal
Years
2000 2001 2009 2010 Total
International Endodontic Journal 1 3 5 4 13
Journal of Endodontics 3 4 13 17 37
Total 4 7 18 21 50
Table 2. Sample size calculation criteria in two periods of time in two endodontic journals (NS: non-significant)
Sample size calculation criteria in two periods of time in two endodontic journals (%)
Yes No Total P-value
2000-1 0 (0.0) 11 (100.0) 11 (100.0) 0.002
2009-10 20 (51.3) 19 (48.7) 39 (100.0)
Total 20 (40.0) 30 (60.0) 50 (100.0)
Method of estimation of prevalence or standard (%)
No sample size calculation Previous studies Pilot studies Assumption Total
2000-1 11 (100.0) 0 (0.0) 0 (0.0) 0 (0.0) 11 (100.0)
2009-10 22 (56.4) 4 (10.2) 1 (2.5) 12 (30.0) 39 (100.0)
Total 33 (66.0) 4 (8.0) 1 (2.0) 12 (24.0) 50 (100.0)
Reporting clinically importance level (%)
Yes No Total P-value
2000-1 0 (0.0) 11 (100.0) 11 (100.0) 0.003
2009-10 19 (48.7) 20 (51.3) 39 (100.0)
Total 19 (38.0) 31 (62.0) 50 (100.0)
Different types of control groups (%)
Alternative treatment Placebo Both of them Total P-value
2000-1 6 (54.5) 3 (27.3) 2 (18.2) 11 (100.0) NS
2009-10 30 (76.9) 3 (7.7) 6 (15.4) 39 (100.0) NS
Total 36 (72.0) 6 (12.0) 8 (16.0) 50 (100.0) NS
Different types of study design (%)
Parallel Cross over Total P-value
2000-1 11 (100.0) 0 (0.0) 11 (100.0) NS
2009-10 29 (74.4) 10 (25.6) 39 (100.0) NS
Total 40 (8.0) 10 (20.0) 50 (100.0) NS
size of each paper. Results showed that in most of the trials the
power was not high enough to detect the differences [5]. In
another study, the reporting of sample size calculation in RCTs
and rehabilitation (PM&R) was assessed systemically. They
found that in 2008, 57.3% of the articles reported sample size
calculation compared to only 3.4% in 1998 and that the articles
often failed to report effect size for sample size calculation [6].
An article by Greenstein et al. [7], compared clinical
versus statistical significance in efficacy of periodontal
therapy, and concluded that clinically important results
should be defined before initiating a study and tests for
determining the statistical significance should be used to
validate those findings that did not occur by chance.
Usually, calculating the sample size for trials requires type
I ( ) and type II ( ) error, event rate in the control group, and
event rate in the treatment group. Also the smallest effect of
interest as the minimal difference between the studied groups
that the investigator wishes to detect, and the population
variance of a given outcome variable, are needed [8].
Because of the importance of appropriate sample size in
research methodology, exploring the sample size estimation
in published high rank papers, might illustrate the weak
points in this regard and help to generate more specific
guidelines for writing scientific papers especially in the field
of clinical trials.
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Table3. Reporting sample size calculation in two endodontic journals (NS: non-significant)
Journal
Sample size calculation (%)
Yes No Total P-value P-value
International Endodontic Journal 3 (23.1) 10 (76.9) 13 (100.0) NS
Journal of Endodontics 17 (45.9) 20 (54.1) 37 (100.0) NS
Total 20 (40.0) 30 (60.0) 50 (100.0) NS
The aim of this article was to evaluate the quality of
reporting the sample size calculation in clinical trials
published in two leading endodontic journals (Journal of
Endodontics and International Endodontic journal) in years
2000-1 and 2009-10.
Methods and Materials
The extracted data from each article consisted of the name of
the journal, publication year, research design (parallel versus
cross over), types of control group (alternative treatment,
placebo or both), reporting sample size calculation (yes or no),
the number of participants in each group, mean number of the
participants in all research groups, study outcome (positive,
used for estimating prevalence or standard deviation (previous
studies, pilot studies or assumption), percentage of meeting
expected sample size and considering clinically importance
level in sample size calculation.
Data were extracted by two investigators (A.SH and M.R)
and checked by other author (A.A.H). Any disagreements were
resolved by a group consensus. Data were entered in Excel data
sheet.
Statistical analysis
Statistical analysis was mainly done by descriptive methods.
Also, comparing the means and proportions between groups
was done by independent T-test and Chi-square analyses. A
P-value of 0.05 was considered significant.
Results
A total number of 50 clinical trials published in Journal of
Endodontics and International Endodontic Journal in years
2000-1 and 2009-10, were reviewed. Frequency distribution of
reviewed clinical trials in two journals in different years of
publication can be seen in Table 1.
In 45 (90%) papers, type I error was 0.05 and the rest of
the articles did not report any value for type I error. In 30
(60%) papers, Type II error was not reported, in 7 (14%) papers
the value was 0.10, in 11 (22%) the value was 0.2 and in 2 (4%)
papers, other values were reported for type II error.
A significant increase in terms of reporting sample size
calculation in years between 2009 and 10 compared to 2000-1
was evident (P=0.002) (Table 2). But the difference between
two journals regarding the report of sample size calculation was
not significant (P>0.05) (Table 3). There was a significant
increase in reporting clinically importance level in 2009-10 in
comparison with 2000-1 (P=0.003) (Table 2). But the
differences in type of control group in different periods of time
and also the two periods of time in frequency of various study
designs (Parallel or cross-over) was not significant (P>0.05)
(Table 2).
There was a significant increase in sample size in 2009-10
(37.89±35.51) compared to 2000-1 (21.7±8.28) (P=0.01).
Twenty five (50%) papers, had positive and 25 (50%) had
negative results. There was not any significant difference for
frequency of positive and negative clinical trials between two
periods of time (P>0.05). Also there was no significant
difference between positive and negative clinical trials
regarding mean sample size per each group (P>0.05). The
difference between the mean of sample size in clinical trials
with parallel and cross-over designs, was not significantly
different (P>0.05).
In all published papers which had reported the sample size
calculation, authors met expected sample size which had been
determined before beginning of the trials. Frequencies of
positive and negative clinical trials between different types of
control groups and also groups reporting or not reporting
sample size calculation, did not show a significant difference,
either (P>0.05).
Discussion
None of the eleven clinical trials published in 2000-1 described
sample size calculation, but in 2009-10, 51.3% of reviewed
papers had considered reporting sample size calculation.
Despite significant higher percentage of reporting sample size
calculation in endodontic journals in recent years compared to
10 years earlier, in almost half of included papers, the method
of sample size calculation was not reported. The rate of
reporting sample size calculation in International Endodontic
Journal and in Journal of Endodontics was 23.1% and 45.9%,
respectively. In CONSORT guideline, the importance of
describing sample size calculation is emphasized as an essential
part in reporting clinical trials [3].
Of the total 50 published clinical trials in Journal of
Endodontics and International Endodontic Journal in years
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2000-1 and 2009-10, 37 papers were in Journal of Endodontics
and 13 were in International Endodontic Journal. In recent
years there has been a positive trend for publication of clinical
trials in these journals. Considering increased attention to
Evidence-based dentistry and the role of well-designed RCTs in
answering clinical questions, this is not surprising. Abdul Latif
et al. showed a 3-fold increase in publication of RCTs in 5
leading journals in physical medicine and rehabilitation from
1998 till 2008 [6], but Diener et al. showed that after 2000,
there was declining frequency in publishing RCTs in German
surgical journal Der Chirurg [9].
To identify all clinical trials published in endodontic
journals, hand searching was done. Some authors mentioned
that hand searching is still necessary and more sensitive in
comparison to electronic searching alone to find published
clinical trials [10].
and variability or standard deviation in case of a continuous
not reported in 10% and 60% of reviewed clinical trials,
respectively. Type I error is often set at 0.05 but Type II error
has been set at different values such as 0.10%, 20%, and etc. In
another study which reviewed clinical trials published in
journal of Physical Medicine and Rehabilitation, authors
respectively [6].
For sample size calculation in clinical trials, estimation of
standard deviation or prevalence in both experimental and
control groups, is essential. To have more accurate
estimation, conducting pilot studies or extracting information
from previous similar studies are recommended [8].
From 17 reviewed papers published between 2009 and
2010 in which the sample size calculation was reported, 4
papers used the previous studies for prior estimation of
prevalence or standard deviation and in one paper, pilot study
was used. In other 12 papers, the method of estimation was
not mentioned.
Previous evaluations of RCT papers often showed
P-value is
less than 0.05, the difference is considered significant and if
P-value is higher than 0.05, the difference between groups will
be considered non-significant. This P-value is not very
important and only shows what the probability of obtaining
result only by chance, is. The P-value doesn’t indicate if the
effect is clinically important. Clinically important results
should be defined before initiating a study because it is
possible for a procedure to provide a statistically significant
improvement, while the result may not be clinically
important. In 2000-1 none of the reviewed papers in this
study reported clinically significant differences between
groups but 48.7 % of reviewed papers in 2009-10, reported
clinically important differences.
A study in Physical Medicine and Rehabilitation journal,
which had evaluated sample size calculation authors showed
that 26.8% of the trials reported a method for calculating
effect estimation by clinically important effect size [6].
Another study compared statistically significant
differences with clinical importance difference in clinical
trials conducted on low back pain; of the 43 included studies,
only six showed both clinically important and statistically
Researchers can consider control groups as active
treatment (alternative treatment) or placebo or both. Seventy-
two percent of reviewed articles in the current study had an
active control group, 12% had placebo as control group and
16% had both. Clearly in endodontic clinical trials,
researchers preferred an alternative treatment as a control
group instead of placebo. Due to ethical consideration for
using placebo as a control group in clinical research, these
findings are sensible. This result is comparable to findings of
a systematic review which evaluated the clinical trials in
Physical Medicine and Rehabilitation journal. In that study,
most control groups were active alternative treatments [6].
While none of reviewed clinical trials in 2000-1 had
cross-over design, 20% of endodontic clinical trials in 2009-
10, had cross-over design. The advantage of this design over a
parallel group is that, the effects of the treatments are
compared within the same patients. Cross-over design always
requires fewer patients than the completely randomized ones
[12]. In recent years, it is obvious that endodontic researchers
use cross-over design to conduct clinical trials more than
before.
Mean sample size per each group in clinical trials
published in 2009-10 was 37.88 compared to 21.69 in 2000-1
and there was a statistically significant difference. Increasing
sample size could be related to improved sample size
calculation in endodontic clinical trials in recent years.
Number of positive and negative clinical trials was equal
in reviewed articles (25 articles). Positive clinical trials were
those studies with significant P-value for the difference in
favor of the experimental group. In contrary, negative clinical
trials, did not result in statistical significance. The mean
sample size was not significantly different in positive and
negative outcomes, and there was not any significant
difference between proportions of result outcome in two-year
groups. There was not a statistically significant difference in
frequencies of positive and negative clinical trials between
groups in which sample size calculation had been reported.
All of the reviewed clinical trials which had reported the
sample size determination met expected sample size and there
were more or at least equal participants in analysis portion of
article compared to predetermined sample size.
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Conclusion
Reported sample size calculations in endodontic clinical trials
has significantly improved in 2009-10 compared to 2000-1 but
it still has room for improvement. The difference between
“Journal of Endodontics” and “International Endodontic
Journal” in reporting sample size calculation was not
significant.
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